Home
Live Updates
Quadruplet Shows Excellent Activity in Myeloma Patients Who Defer HSCT : comparemela.com
Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT
ORR reaches 90% with isatuximab plus KRd in newly diagnosed disease
Related Keywords
Massachusetts ,
United States ,
Wisconsin ,
Dana Farber Cancer Institute ,
Boston ,
Mike Bassett ,
Elizabeth Odonnell ,
Natalie Callander ,
Wisconsin Institutes For Medical Research In Madison ,
Elizabetho Donnell ,
Wisconsin Institutes ,
Medical Research ,
comparemela.com © 2020. All Rights Reserved.